Page last updated: 2024-08-25

eriocitrin and Cancer of Liver

eriocitrin has been researched along with Cancer of Liver in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Fan, X; Gan, C; Qi, S; Qi, Z; Zhang, Y; Zhou, H1
Chen, K; Chen, L; Huang, Z; Wang, Z; Zhang, H; Zhang, X; Zhou, J1

Other Studies

2 other study(ies) available for eriocitrin and Cancer of Liver

ArticleYear
[Eriocitrin suppresses proliferation and migration of hepatocellular carcinoma SMMC-7721 cells by promoting ROS production and activating the MAPK pathway].
    Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2023, Mar-20, Volume: 43, Issue:3

    Topics: Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Humans; Liver Neoplasms; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Poly(ADP-ribose) Polymerase Inhibitors; Reactive Oxygen Species

2023
Eriocitrin from lemon suppresses the proliferation of human hepatocellular carcinoma cells through inducing apoptosis and arresting cell cycle.
    Cancer chemotherapy and pharmacology, 2016, Volume: 78, Issue:6

    Topics: Activating Transcription Factor 1; Apoptosis; Carcinoma, Hepatocellular; Caspases; Cell Cycle Checkpoints; Cell Proliferation; Cell Transformation, Neoplastic; Citrus; Cyclic AMP Response Element-Binding Protein; Flavanones; Hep G2 Cells; Humans; Liver Neoplasms; MAP Kinase Signaling System; Phosphorylation

2016